Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma Academic Article uri icon

Overview

MeSH Major

  • Brain Neoplasms
  • Glioblastoma
  • Indoles
  • Lomustine
  • Neoplasm Recurrence, Local

abstract

  • Enzastaurin was well tolerated and had a better hematologic toxicity profile but did not have superior efficacy compared with lomustine in patients with recurrent glioblastoma.

publication date

  • March 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2834468

Digital Object Identifier (DOI)

  • 10.1200/JCO.2009.23.2595

PubMed ID

  • 20124186

Additional Document Info

start page

  • 1168

end page

  • 74

volume

  • 28

number

  • 7